Overview

Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation

Status:
Unknown status

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Eltrombopag may shorten time to platelet engraftment after allogeneic cord blood transplantation.

Phase:

Phase 2

Details

Lead Sponsor:

Rabin Medical Center